T

Researcher Profile

Tomomichi Fujitani

🏛 1Daiichi Sankyo Co., Ltd., Tokyo, Japan.

1

Publications

269

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article Molecular Cancer Therapeutics Aug 19, 2021

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells

Daisuke Okajima · Satoru Yasuda · Takanori Maejima · Tsuyoshi Karibe +19 more

10.1158/1535-7163.mct-21-0206 269 citations

Publication Timeline

2021

1

Frequent Co-Authors

Tomoko Shibutani

Takanori Maejima

Daisuke Okajima

Michiko Kitamura